Innate Pharma Stock
Innate Pharma Stock
The Innate Pharma stock is trending slightly upwards today, with an increase of €0.004 (0.290%) compared to yesterday's price.
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0.290% | -5.132% | -7.317% | -28.898% | -10.588% | -53.215% | -63.265% |
| Nanobiotix | 1.750% | 12.621% | 61.650% | 833.076% | 51.832% | 803.427% | 123.421% |
| Poxel S.A. | -0.420% | -9.981% | -24.724% | 31.319% | 0.000% | -65.857% | -96.271% |
| Adocia | -0.610% | -2.999% | -0.154% | 32.041% | -1.970% | 97.256% | -39.646% |
